20 Analysts Have This to Say About Amgen
Portfolio Pulse from Benzinga Insights
20 analysts have given their ratings on Amgen (NASDAQ:AMGN) in the last quarter, with 6 bullish, 4 somewhat bullish, and 10 indifferent. The average price target is $286.1, compared to the current price of $265.67, implying an upside. The average price target has increased by 4.65% over the past month.
November 09, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Amgen has received mostly positive ratings from analysts, with an average price target that suggests an upside from the current price. The average price target has also increased over the past month.
The majority of the 20 analysts have given bullish or somewhat bullish ratings for Amgen, indicating a positive outlook for the stock. The average price target is also higher than the current price, suggesting potential upside. Furthermore, the increase in the average price target over the past month indicates growing optimism among analysts.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100